查尔森和埃利克豪泽方法的比较,用于预测胃切除术中的护理指标,与胃癌患者进行比较
1Department of Nursing, Chungbuk National University, Cheongju 28644, Republic of Korea.
Healthcare (Basel, Switzerland)
|July 14, 2023
概括
埃利克沙瑟并发症指数 (ECI) 比查尔森并发症指数 (CCI) 更好地预测胃癌手术后大多数护理敏感结果 (NSO). 对于特定的NSO来说,最佳指数有所不同,这凸显了对量身定制方法的需求.
科学领域:
- 医疗信息学 医疗信息学
- 医疗保健管理的管理
- 瘤学 护理 护理专业
背景情况:
- 像查尔森 (CCI) 和埃利克沙瑟 (ECI) 这样的并发症指数对于根据病情严重程度调整患者护理至关重要.
- 护理敏感结果 (NSOs) 是患者健康状况的改善,直接受到护理的影响.
- 没有先前的研究直接比较了CCI和ECI对NSO的预测性能.
研究的目的:
- 为了比较查尔森并发症指数 (CCI) 和埃利克沙瑟并发症指数 (ECI) 对护理敏感结果 (NSO) 的预测准确度.
- 评估哪个并发症指数在预测胃切除术的胃癌患者中各种NSO方面优越.
主要方法:
- 使用来自韩国保险审查和评估服务数据库 (2015-2016) 的数据进行了回顾性队列研究.
- 纳入标准:19岁以上经过胃切除术的胃癌患者.
- 使用后勤回归分析来评估NSO和CCI/ECI之间的关系,并根据患者和医院的特点进行调整.
主要成果:
- 埃利克沙瑟并发症指数 (ECI) 项目模型在总NSO,生理/代谢障碍和深静脉血栓形成方面表现出卓越的表现 (C-统计,AIC).
- 对于住院死亡率,中枢神经系统并发症,休克/心脏骤停,尿路感染,肺衰竭和伤口感染,ECI的表现也超过了CCI.
- 查尔森并发症指数 (CCI) 项目模型在上胃肠道出血,医院获得的肺炎和压力方面表现优异.
结论:
- 埃利克沙瑟并发症指数 (ECI) 项目模型在预测胃切除术后胃癌患者的11种护理敏感结果 (NSO) 中的8种方面表现出色.
- 预测特定NSO的最佳并发症指数有所不同,这表明需要采用微妙的方法.
- 这些发现对手术瘤护理的风险分层和资源分配有影响.
更多相关视频
03:32Single Incision Plus One Port Laparoscopic Proximal Gastrectomy with Double Channel Anastomosis for Gastric Cancer Treatment
Published on: December 27, 2024
824
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
306
相关概念视频
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
201
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
201
Cancer Survival Analysis
394
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
394
Comparing the Survival Analysis of Two or More Groups
226
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
226
Kaplan-Meier Approach
188
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
188
